The Study
Effects of liraglutide on abdominal fat distribution and glucose metabolism in Chinese subjects with obesity
This study watched what happened to 71 people who took a medicine called liraglutide for 12 weeks. They lost weight and their blood sugar got better, but we don’t know if the medicine caused it — maybe they ate better or exercised more without telling anyone.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
A medicine called liraglutide, used for weight and blood sugar control, was given to obese people for 12 weeks. It made their liver fat drop a lot — even more than their belly fat — and their blood sugar got better.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 548 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — reducing liver fat by over half in just 3 months is a big deal, as it’s linked to reversing prediabetes and lowering diabetes risk.
- 2Liver fat dropped by 55.4%.
- 3Fasting blood sugar fell by 0.62 mmol/L.
- 4HbA1c dropped by 0.59%.
- 5Weight dropped by 6.6%.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Diabetology & Metabolic Syndrome
Year
2024
Authors
M. Du, Jiang Yue, Yi-Cheng Qi, Shengyun He, Xiaobing Lu, Minglan Yang, Li-Hui Wang, Qing Lu, Jing Ma
Related Content
Claims (4)
In obese Chinese adults, taking liraglutide at 1.8 mg daily for 12 weeks lowers fasting blood glucose by 0.62 mmol/L, reduces 2-hour post-meal glucose by 2.95 mmol/L, and decreases HbA1c by 0.59%, which represents a measurable improvement in glucose metabolism.
In obese Chinese adults, taking 1.8 mg of liraglutide daily for 12 weeks reduces liver fat by 55.4% as measured by MRI, and this reduction is linked to lower fasting blood glucose and HbA1c levels.
In obese Chinese adults, taking liraglutide at 1.8 mg per day for 12 weeks leads to a 6.6% loss in body weight and reduced abdominal fat, but these changes do not correspond to changes in fasting glucose or HbA1c levels.
Among obese Chinese adults with impaired glucose regulation, taking liraglutide 1.8 mg daily for 12 weeks results in a greater reduction in liver fat compared to obese Chinese adults with normal glucose regulation.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.